Resveratrol Decreases the Resistance of Lung Cancer Cells to EGFR Tyrosine Kinase Inhibitor
碩士 === 中國醫藥大學 === 癌症生物學研究所 === 98 === Lung cancer is one of the most common malignancies in many countries, including Taiwan, and also is the first leading cause of cancer-induced death. EGFR (epidermal growth factor receptor) regulated a lot of biological functions of cells including proliferation,...
Main Authors: | Chu-Ying Peng, 彭竺英 |
---|---|
Other Authors: | Jen-Liang Su |
Format: | Others |
Language: | en_US |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/16102696077040719384 |
Similar Items
-
Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
by: Wang J, et al.
Published: (2016-06-01) -
Mechanisms of resistance to EGFR tyrosine kinase inhibitors
by: Lihua Huang, et al.
Published: (2015-09-01) -
Mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
by: Gergis, Carol
Published: (2019) -
Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports
by: Shi X, et al.
Published: (2020-07-01) -
Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with <i>EGFR</i> Mutations
by: Kenichi Suda, et al.
Published: (2021-06-01)